Hudson Bay Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,200
Closed -$18.7K 937
2025
Q1
$18.7K Buy
+12,200
New +$18.7K ﹤0.01% 826